Search Results Search Sort by RelevanceMost Recent Policy Forum Mar 2016 Medical Malpractice Reform: Historical Approaches, Alternative Models, and Communication and Resolution Programs Joseph S. Kass, MD, JD and Rachel V. Rose, JD, MBA Alternatives to suing could help open communication between injured patients and clinicians. AMA J Ethics. 2016;18(3):299-310. doi: 10.1001/journalofethics.2016.18.3.pfor6-1603. Policy Forum Mar 2023 What Should Be Clinicians’ Roles in Regulatory Assessment of Prospective Interventions’ Risks of Exacerbating Inequity? Anushka Bhaskar and Daniel Carpenter, PhD When regulatory decisions express overconfidence, one risk is that the costliness or misinformation will exacerbate health inequity. AMA J Ethics. 2023;25(3):E204-209. doi: 10.1001/amajethics.2023.204. Policy Forum Sep 2009 Direct-to-Consumer Personal Genome Services: Need for More Oversight Emily E. Anderson, PhD, MPH There is a market for direct-to-consumer genetic testing and a need for better consumer information and more regulation of tests and testing laboratories. Virtual Mentor. 2009;11(9):701-708. doi: 10.1001/virtualmentor.2009.11.9.pfor1-0909. Policy Forum Sep 2009 Emerging Dilemmas in Newborn Screening Don B. Bailey, Jr, PhD, Debra Skinner, PhD, Myra I. Roche, MS, CGC, and Cynthia Powell, MD, MS Research questions must be answered to inform policy decisions about the hereditary diseases and conditions for which newborns should be tested. Virtual Mentor. 2009;11(9):709-713. doi: 10.1001/virtualmentor.2009.11.9.pfor2-0909. Policy Forum Mar 2004 Content of Medical Error Disclosures Thomas H. Gallagher, MD A basic standard for error disclosure for physicians needs to be developed, which will enhance the patient-physician relationship. Virtual Mentor. 2004;6(3):132-135. doi: 10.1001/virtualmentor.2004.6.3.pfor1-0403.
Policy Forum Mar 2016 Medical Malpractice Reform: Historical Approaches, Alternative Models, and Communication and Resolution Programs Joseph S. Kass, MD, JD and Rachel V. Rose, JD, MBA Alternatives to suing could help open communication between injured patients and clinicians. AMA J Ethics. 2016;18(3):299-310. doi: 10.1001/journalofethics.2016.18.3.pfor6-1603.
Policy Forum Mar 2023 What Should Be Clinicians’ Roles in Regulatory Assessment of Prospective Interventions’ Risks of Exacerbating Inequity? Anushka Bhaskar and Daniel Carpenter, PhD When regulatory decisions express overconfidence, one risk is that the costliness or misinformation will exacerbate health inequity. AMA J Ethics. 2023;25(3):E204-209. doi: 10.1001/amajethics.2023.204.
Policy Forum Sep 2009 Direct-to-Consumer Personal Genome Services: Need for More Oversight Emily E. Anderson, PhD, MPH There is a market for direct-to-consumer genetic testing and a need for better consumer information and more regulation of tests and testing laboratories. Virtual Mentor. 2009;11(9):701-708. doi: 10.1001/virtualmentor.2009.11.9.pfor1-0909.
Policy Forum Sep 2009 Emerging Dilemmas in Newborn Screening Don B. Bailey, Jr, PhD, Debra Skinner, PhD, Myra I. Roche, MS, CGC, and Cynthia Powell, MD, MS Research questions must be answered to inform policy decisions about the hereditary diseases and conditions for which newborns should be tested. Virtual Mentor. 2009;11(9):709-713. doi: 10.1001/virtualmentor.2009.11.9.pfor2-0909.
Policy Forum Mar 2004 Content of Medical Error Disclosures Thomas H. Gallagher, MD A basic standard for error disclosure for physicians needs to be developed, which will enhance the patient-physician relationship. Virtual Mentor. 2004;6(3):132-135. doi: 10.1001/virtualmentor.2004.6.3.pfor1-0403.